Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Child Opportunity Index and 30-Day Readmission Among Children Discharged With New Long-Term Mechanical Ventilation via Tracheostomy: A Pediatric Health Information System Database Study, 2014-2023.

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·2026
Same author

Tau topography subtypes account for clinical heterogeneity and longitudinal trajectories in early-onset Alzheimer's disease.

Brain communications·2026
Same author

The Mediating Role of Depression in the Relationship Between Physical Activity and Quality of Life Among Patients with Coronary Heart Disease.

Western journal of nursing research·2026
Same author

A single large-scale mitochondrial DNA deletion presenting as rapidly progressive dementia in a 35-year-old male.

NPJ dementia·2026
Same author

The Role of Socioeconomic Status in the Association between Genetic Predisposition and Cardiovascular Events: A UK Biobank Study.

The American journal of cardiology·2026
Same author

The child opportunity index and discharge disposition among children with new tracheostomy and long-term mechanical ventilation.

Annals of the American Thoracic Society·2026
Same journal

Evidence for progressive neurodegeneration in iatrogenic cerebral amyloid angiopathy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Human brain connectome profiles mediate the relationship between pathology burden and clinical phenotypes in Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Kat5 cKO mouse replicates biological domain signatures associated with Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Evaluation of CSF and plasma tau species as fluid surrogate candidates for tau PET in prodromal to moderate Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Associations of self-reported obstructive sleep apnea with cognition and dementia risk in cognitively unimpaired middle-aged adults.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Inflammation profiles in Alzheimer's disease relate to cognition and neurodegeneration.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Chidera Agwu1, Charles C Windon2, Thomas J Hoffmann3

  • 1Washington University School of Medicine in St. Louis, St. Louis, CO, USA.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
PubMed
概括
此摘要是机器生成的。

少数群体,特别是黑人和西班牙裔个人,在阿尔茨海默病和痴呆症的误诊率更高. 像MMSE和MoCA这样的认知测试可能会加剧这些差异,突出了对文化敏感的诊断方法的需求.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

科学领域:

  • 神经学 神经学
  • 老年学是一门学科.
  • 健康差异 在健康上的差异

背景情况:

  • 阿尔茨海默病 (AD) 患病率随着年龄的增长而增加,不成比例地影响着各种人群.
  • 系统性障碍,包括医疗保健的获取和互动,有助于诊断挑战.
  • 准确的诊断对于管理AD患者的认知缺陷和痴呆症至关重要.

研究的目的:

  • 调查客观认知障碍措施与AD生物标志物之间的不一致性.
  • 检查医疗保健提供者的互动如何影响跨种族群体诊断和生物标志物之间的关系.

主要方法:

  • 利用了国家阿尔茨海默氏症协调中心 (NACC) 来自180,039名患者的数据.
  • 分析了迷你心理状态检查 (MMSE) 和蒙特利尔认知评估 (MoCA) 的得分,以及脑脊液 (CSF) 的生物标志物 (粉样蛋白-β,总,-).
  • 使用回归分析来评估跨种族群体的认知得分,生物标志物和临床诊断之间的关联,将少数群体与白人患者进行比较.

主要成果:

  • 24.5%的具有生物标志物数据的患者被确定为少数群体 (n=3050).
  • 黑人和西班牙裔患者在医生诊断和所有AD生物标志物之间显示出显著的不一致.
  • 与白人患者相比,MMSE得分还显示了黑人和西班牙裔患者的显著不一致.

结论:

  • 某些少数群体面临更高的痴呆误诊的可能性,特别是当使用特定的认知测试时.
  • 认知测试措施受到需要进一步调查的因素的影响.
  • 诊断工具和临床评估必须适应,以考虑到AD诊断中的不同患者群体.